COVID-19 Vaccination acceptability among Type 2 Diabetes Mellitus Patients in a tertiary hospital in Southwest Nigeria: a cross-sectional study
Keywords:
COVID-19, Vaccine, Acceptance, Type 2 diabetes, NigeriaAbstract
Background: The mortality from COVID-19 is higher in diabetes mellitus (DM) patients compared to the general population, hence it is highly desirable that DM patients are vaccinated against COVID-19 infection
Aim: To determine the willingness of type 2 DM patients to accept COVID-19 vaccine and associated factors.
Methods: This was a cross-sectional descriptive study that involved DM patients. A structured questionnaire was used for data collection. Multivariable logistic regression was used to assess factors associated with willingness to be vaccinated.
Results: A total of 302 DM patients participated in the study. About 90% of the respondents perceived COVID-19 to be a serious disease; however, 33.5% of the patients considered themselves to be at risk of contracting COVID-19 despite having DM. About 70.0% of the DM patients were willing to receive the vaccine. Factors associated with willingness to be vaccinated were perception of COVID-19 as a severe disease (Adjusted odds ratio (AOR), 6.09; 95% CI, 4.96−12.27), previous vaccination (AOR, 1.58; 95% CI, 1.04−2.98), and higher education (AOR, 2.36; 95% CI, 1.04−6.86).
Conclusion: About a third of the study participants were not willing to receive COVID-19 vaccination. There is need to educate the at-risk population about the importance of COVID-19 vaccination.
References
WHO Situation Report on COVID-19. Available from: https://www.who.int/ emergencies/ diseases/novel-coronavirus-2022/situation-reports Accessed 26th April 2023
WHO Director General’s opening remarks at media briefing on COVID-19 on March 11, 2020 Available from: https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020
How to protect yourself and others.https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/prevention.html access 26th April 2023
Lin DY, Gu Y, Wheeler B, Young H, Holloway S, Sunny SK et al. Effectiveness of Covid-19 Vaccines over a 9-Month Period in North Carolina. N Engl J Med. 2022;386(10):933-941
Whittaker R, Kristofferson AB, Salamanca BV, Seppälä E, Golestani K, Kvåle R et al. Length of hospital stay and risk of intensive care admission and in-hospital death among COVID-19 patients in Norway: a register-based cohort study comparing patients fully vaccinated with an mRNA vaccine to unvaccinated patients. Clinical Microbiology and Infection. 2022 Jun 1;28(6):871-8.
Palamenghi L, Barello S, Boccia S, Graffigna G. Mistrust in biomedical research and vaccine hesitancy: the forefront challenge in the battle against COVID-19 in Italy. European Journal of Epidemiology. 2020;35(8):785-8.
Threat-emerging-re-emerging-infectious-diseases-global:https://www.weforum.org/agenda /2019/01/10 -global-health-threats-to-watch-in-2019-accesed 30th April 2023
Casqueiro J, Casqueiro J, Alves C. Infections in patients with diabetes mellitus: A review of pathogenesis. Indian J Endocrinol Metab. 2012;16 (Suppl1):S27-36.
Espiritu AI, Chiu HH, Sy MC, Anlacan VM, Jamora RD. The outcomes of patients with diabetes mellitus in The Philippine CORONA Study. Scientific reports. 2021 Dec 24;11(1). https://doi.org/10.1038/s41598-021-03898-1 (30th April 2023)
Sonmez A, Demirci I, Haymana C, Tasci I, Dagdelen S, Salman S et al. Clinical characteristics and outcomes of COVID-19 in patients with type 2 diabetes in Turkey: A nationwide study (TurCoviDia). J Diabetes. 2021;13(7):585-595.
Rastad H, Karim H, Ejtahed HS, Tajbakhsh R, Noorisepehr M, Babaei M et al. Risk and predictors of in-hospital mortality from COVID-19 in patients with diabetes and cardiovascular disease. Diabetol Metab Syndr. 2020;12:57. doi: 10.1186/s13098-020-00565-9.
Albitar O, Ballouze R, Ooi JP, Sheikh Ghadzi SM. Risk factors for mortality among COVID-19 patients. Diabetes Res Clin Pract. 2020;166:108293. doi: 10.1016/j.diabres.2020.108293
Kish L. Survey sampling. American Political Science Review, Cambridge University Press, vol. 59(4), 1025-1025 .
Aldossari KK, Alharbi MB, Alkahtani SM, Alrowaily TZ, Alshaikhi AM, Twair AA. COVID-19 vaccine hesitancy among patients with diabetes in Saudi Arabia. Diabetes Metab Syndr. 2021 Sep-Oct;15(5) :102271.
Halter JB, Musi N, Horne FMF, et al. Diabetes and Cardiovascular Disease in Older Adults: Current Status and Future Directions. Diabetes. 2014;63(8):2578. doi:10.2337/DB14-0020
Nordström A, Hadrévi J, Olsson T, Franks PW, Nordström P. Higher prevalence of type 2 diabetes in men than in women is associated with differences in visceral fat mass. J Clin Endocrinol Metab. 2016;101(10):3740-3746. doi:10.1210/jc.2016-1915
Siddiqui MA, Khan MF, Carline TE. Gender Differences in Living with Diabetes Mellitus. Mater Sociomed. 2013;25(2):140. doi:10.5455/MSM.2013.25.140-142
Kautzky-Willer A, Harreiter J, Pacini G. Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus. Endocr Rev. 2016;37(3):278. doi:10.1210/ER.2015-1137
Ostlin P. Gender inequalities in occupational health. Boston: Harvard University; 2000. p. 5.
Syan SK, Gohari MR, Levitt EE, et al. COVID-19 Vaccine Perceptions and Differences by Sex, Age, and Education in 1,367 Community Adults in Ontario. Front Public Heal. 2021;9:1244. doi:10.3389/FPUBH.2021.719665/BIBTEX
Jabessa D, Bekele F. Willingness to receive the COVID-19 vaccine and associated factors among residents of Southwestern Ethiopia: A cross-sectional study. Patient Prefer Adherence. 2022;16:1177. doi:10.2147/PPA.S362264
Aldossari KK, Alharbi MB, Alkahtani SM, Alrowaily TZ, Alshaikhi AM, Twair AA. COVID-19 vaccine hesitancy among patients with diabetes in Saudi Arabia. Diabetes Metab Syndr. 2021;15(5):102271. doi:10.1016/J.DSX.2021.102271
Cariou B, Hadjadj S, Wargny M, Pichelin M, Al-Salameh A, Allix I, et al. Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study. Diabetologia. 2020;63(8):1500-1515. doi:10.1007/S00125-020-05180-X/TABLES/6
Omar SM, Khalil R, Adam I, Al-Wutayd O. The Concern of COVID-19 Vaccine Safety Is behind Its Low Uptake among Patients with Diabetes Mellitus in Sudan. Vaccines 2022, Vol 10, Page 527. 2022;10(4):527. doi:10.3390/VACCINES10040527
Xu J, Chen S, Wang Y, Duan L, Li J, Shan Y, et al. Prevalence and Determinants of COVID-19 Vaccination Uptake Were Different between Chinese Diabetic Inpatients with and without Chronic Complications: Cross-Sectional Survey. Vaccines. 2022;10(7):994. doi:10.3390/vaccines10070994
Wu L, Wang X, Li R, Huang Z, Guo X, Liu J, Yan H, Sun X. Willingness to Receive a COVID-19 Vaccine and Associated Factors among Older Adults: A Cross-Sectional Survey in Shanghai, China. Vaccines (Basel). 2022 Apr 21;10(5):654.
Hassen HD, Welde M, Menebo MM. Understanding determinants of COVID-19 vaccine hesitancy; an emphasis on the role of religious affiliation and individual’s reliance on traditional remedy. BMC Public Heal 2022 221. 2022;22(1):1-11. doi:10.1186/S12889-022-13485-2
Osuagwu UL, Langsi R, Ovenseri-Ogbomo G, Mashige KP, Abu EK, Envuladu EA et al. Analysis of Perception, Reasons, and Motivations for COVID-19 Vaccination in People with Diabetes across Sub-Saharan Africa: A Mixed-Method Approach. Int J Environ Res Public Health. 2022;19(13):7875. doi:10.3390/IJERPH19137875
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Research Journal of Health Sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Research Journal of Health Sciences journal is a peer reviewed, Open Access journal. The Journal subscribed to terms and conditions of Open Access publication. Articles are distributed under the terms of Creative Commons License (CC BY-NC-ND 4.0). (http://creativecommons.org/licences/by-nc-nd/4.0). All articles are made freely accessible for everyone to read, download, copy and distribute as long as appropriate credit is given and the new creations are licensed under the identical terms.
